scispace - formally typeset
M

Mark S. Sonders

Researcher at Columbia University

Publications -  31
Citations -  5735

Mark S. Sonders is an academic researcher from Columbia University. The author has contributed to research in topics: Dopamine & Dopamine transporter. The author has an hindex of 25, co-authored 31 publications receiving 5206 citations. Previous affiliations of Mark S. Sonders include Oregon Health & Science University & Columbia University Medical Center.

Papers
More filters
Journal ArticleDOI

Mechanisms of neurotransmitter release by amphetamines: a review.

TL;DR: Current issues on the two apparent primary mechanisms--the redistribution of catecholamines from synaptic vesicles to the cytosol, and induction of reverse transport of transmitter through plasma membrane uptake carriers are reviewed.
Journal ArticleDOI

Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits

TL;DR: This work reports increased dendritic spine density with reduced developmental spine pruning in layer V pyramidal neurons in postmortem ASD temporal lobe and suggests that mTOR-regulated autophagy is required for developmental spinePruning, and activation of neuronal Autophagy corrects synaptic pathology and social behavior deficits in ASD models with hyperactivated mTOR.
Journal ArticleDOI

Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

TL;DR: The discovery and pharmacological characterization of a rat G protein-coupled receptor that stimulates the production of cAMP when exposed to the trace amines p-tyramine, beta-phenethylamine, tryptamine, and octopamine and the discovery that amphetamines are potent rTAR1 agonists suggests that the effects of these widely used drugs may be mediated in part by this receptor as well as their previously characterized targets, the neurotransmitter transporter proteins.
Journal ArticleDOI

Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants

TL;DR: The voltage dependence of DA uptake suggests a mechanism through which presynaptic DA autoreceptor activation may accelerate the termination of dopaminergic neurotransmission in vivo.
Journal ArticleDOI

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

TL;DR: It is shown that reboxetine has a superior pharmacological selectivity to existing tricyclic antidepressants and selective serotonin reuptake inhibitors when tested in a large number of in vitro and in vivo systems.